On November 1 this year, an amendment to the Reimbursement Act came into effect. Among other things, it provides for a reduction in patient fees for drugs manufactured in Poland to 10% and those containing domestically produced active substances to 15%. However, until today the Health Ministry has not published a list of them, and pharmacies will not be able to dispense them at a discount to patients. Reductions in patient surcharges may remain an unfulfilled promise, especially for those who are not in the group receiving free drugs.
Despite ongoing discussions between the Health Ministry and drug manufacturers on the implementation of this regulation, no list has been produced to enable implementation.
- W...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
